Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Reiter

Showing results (51-60 of 211) with videos related to

Pageof 22
Sort By:
Archives of Dermatology|June 20, 2007
Imatinib as a treatment option for systemic non-Langerhans cell histiocytosesJochen Utikal, Selma Ugurel, Hjalmar Kurzen, et al.
Blood Advances|January 30, 2020
Treatment-free remission in FIP1L1-PDGFRA-positive myeloid/lymphoid neoplasms with eosinophilia after imatinib discontinuationGeorgia Metzgeroth, Juliana Schwaab, Nicole Naumann, et al.
Genes, Chromosomes & Cancer|February 16, 2010
Atypical mRNA fusions in PML-RARA positive, RARA-PML negative acute promyelocytic leukemiaChristoph Walz, David Grimwade, Susanne Saussele, et al.
Journal of Cancer Research and Clinical Oncology|January 26, 2020
An increased bone mineral density is an adverse prognostic factor in patients with systemic mastocytosisPhilipp Riffel, Juliana Schwaab, Christopher Lutz, et al.
The Journal of Allergy and Clinical Immunology. in Practice|September 26, 2025
Leukocytosis, Monocytosis, and Eosinophilia in Systemic Mastocytosis: Analysis of Phenotype, Genetics and Prognosis in 596 Patients From the GREM RegistryJohannes Lübke, Nicole Naumann, Vito Dangelo, et al.
British Journal of Haematology|August 9, 2025
Midostaurin in daily clinical practice of patients with advanced systemic mastocytosisJohannes Lübke, Nicole Naumann, Timo Brand, et al.
Journal of Cancer Research and Clinical Oncology|September 24, 2013
Effect of the tyrosine kinase inhibitor nilotinib in patients with hypereosinophilic syndrome/chronic eosinophilic leukemia: analysis of the phase 2, open-label, single-arm A2101 studyAndreas Hochhaus, Philipp D le Coutre, Hagop M Kantarjian, et al.
Scientific Reports|January 6, 2024
A clinical, morphological and molecular study of 70 patients with gastrointestinal involvement in systemic mastocytosisJohannes Lübke, Nicole Naumann, Oliver Hoffmann, et al.
Haematologica|April 28, 2010
Transcription factor mutations in myelodysplastic/myeloproliferative neoplasmsThomas Ernst, Andrew Chase, Katerina Zoi, et al.
British Journal of Clinical Pharmacology|March 18, 2010
Competitive inhibition of renal tubular secretion of ciprofloxacin and metabolite by probenecidCornelia B Landersdorfer, Carl M J Kirkpatrick, Martina Kinzig, et al.
Pageof 22

Showing results (51-60 of 211) with videos related to

Sort By:
Pageof 22
Archives of Dermatology|June 20, 2007
Imatinib as a treatment option for systemic non-Langerhans cell histiocytosesJochen Utikal, Selma Ugurel, Hjalmar Kurzen, et al.
Blood Advances|January 30, 2020
Treatment-free remission in FIP1L1-PDGFRA-positive myeloid/lymphoid neoplasms with eosinophilia after imatinib discontinuationGeorgia Metzgeroth, Juliana Schwaab, Nicole Naumann, et al.
Genes, Chromosomes & Cancer|February 16, 2010
Atypical mRNA fusions in PML-RARA positive, RARA-PML negative acute promyelocytic leukemiaChristoph Walz, David Grimwade, Susanne Saussele, et al.
Journal of Cancer Research and Clinical Oncology|January 26, 2020
An increased bone mineral density is an adverse prognostic factor in patients with systemic mastocytosisPhilipp Riffel, Juliana Schwaab, Christopher Lutz, et al.
The Journal of Allergy and Clinical Immunology. in Practice|September 26, 2025
Leukocytosis, Monocytosis, and Eosinophilia in Systemic Mastocytosis: Analysis of Phenotype, Genetics and Prognosis in 596 Patients From the GREM RegistryJohannes Lübke, Nicole Naumann, Vito Dangelo, et al.
British Journal of Haematology|August 9, 2025
Midostaurin in daily clinical practice of patients with advanced systemic mastocytosisJohannes Lübke, Nicole Naumann, Timo Brand, et al.
Journal of Cancer Research and Clinical Oncology|September 24, 2013
Effect of the tyrosine kinase inhibitor nilotinib in patients with hypereosinophilic syndrome/chronic eosinophilic leukemia: analysis of the phase 2, open-label, single-arm A2101 studyAndreas Hochhaus, Philipp D le Coutre, Hagop M Kantarjian, et al.
Scientific Reports|January 6, 2024
A clinical, morphological and molecular study of 70 patients with gastrointestinal involvement in systemic mastocytosisJohannes Lübke, Nicole Naumann, Oliver Hoffmann, et al.
Haematologica|April 28, 2010
Transcription factor mutations in myelodysplastic/myeloproliferative neoplasmsThomas Ernst, Andrew Chase, Katerina Zoi, et al.
British Journal of Clinical Pharmacology|March 18, 2010
Competitive inhibition of renal tubular secretion of ciprofloxacin and metabolite by probenecidCornelia B Landersdorfer, Carl M J Kirkpatrick, Martina Kinzig, et al.
Pageof 22